Iterum Therapeutics Plc (ITRMF)
0.055
+0.01
(+29.72%)
USD |
OTCM |
May 06, 16:00
Iterum Therapeutics Free Cash Flow : -19.63M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amarin Corp. Plc | 25.63M |
| Jazz Pharmaceuticals Plc | 1.186B |
| Prothena Corp. Plc | -168.85M |
| GH Research Plc | -45.04M |
| Cosmo Pharmaceuticals NV | -19.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.855M |
| Cash from Investing (Quarterly) | -0.0126M |
| Cash from Financing (Quarterly) | 5.655M |
| Free Cash Flow Per Share (Quarterly) | -0.1718 |
| Free Cash Flow to Equity (Quarterly) | -9.044M |
| Free Cash Flow to Firm (Quarterly) | -7.297M |
| Free Cash Flow Yield | -974.4% |